Editorial: biologics in the therapy of Crohn's disease-the fog clears

Aliment Pharmacol Ther. 2020 Oct;52(7):1214-1215. doi: 10.1111/apt.16005.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Biological Products* / therapeutic use
  • Crohn Disease* / drug therapy
  • Humans
  • Tumor Necrosis Factor Inhibitors

Substances

  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • Tumor Necrosis Factor Inhibitors
  • vedolizumab